@misc{indiciaeee45dc270497,
  title = {BRAF V600 and ErbB inhibitors directly activate GCN2 in an off-target manner to limit cancer cell proliferation},
  author = {Ill, C. R. and Marikar, N. C. and Nguyen, V. and Nangia, V. and Darnell, A. M. and Vander Heiden, M. G. and Reigan, P. and Spencer, S. L.},
  year = {2024},
  doi = {10.1101/2024.12.19.629301},
  url = {https://www.biorxiv.org/content/10.1101/2024.12.19.629301v1},
  note = {Source identifier: 10.1101/2024.12.19.629301}
}